Skip to main content
Erschienen in: Journal of Gastroenterology 1/2012

01.01.2012 | Letter to the Editor

Oral steroid versus steroid pulse therapy for autoimmune pancreatitis: time to introduce new weapons

verfasst von: Ahad Eshraghian, Hamed Eshraghian

Erschienen in: Journal of Gastroenterology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

Sir, …
Literatur
1.
Zurück zum Zitat Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2011;46:696–704.PubMedCrossRef Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2011;46:696–704.PubMedCrossRef
2.
Zurück zum Zitat Okazaki K, Kawa S, Kamisawa T, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010;45:249–65.PubMedCrossRef Okazaki K, Kawa S, Kamisawa T, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010;45:249–65.PubMedCrossRef
3.
Zurück zum Zitat Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren’s syndrome with rituximab: report of a case and review of the literature. Rheumatol Int. 2009;29(12):1481–5.PubMedCrossRef Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren’s syndrome with rituximab: report of a case and review of the literature. Rheumatol Int. 2009;29(12):1481–5.PubMedCrossRef
4.
Zurück zum Zitat Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology. 2002;122:1264–9.PubMedCrossRef Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology. 2002;122:1264–9.PubMedCrossRef
5.
Zurück zum Zitat Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol. 2008;43:409–18.PubMedCrossRef Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol. 2008;43:409–18.PubMedCrossRef
6.
Zurück zum Zitat Nishio A, Asada M, Uchida K, Fukui T, Chiba T, Okazaki K. The role of innate immunity in the pathogenesis of experimental autoimmune pancreatitis in mice. Pancreas. 2011;40:95–102.PubMedCrossRef Nishio A, Asada M, Uchida K, Fukui T, Chiba T, Okazaki K. The role of innate immunity in the pathogenesis of experimental autoimmune pancreatitis in mice. Pancreas. 2011;40:95–102.PubMedCrossRef
7.
Zurück zum Zitat Lupo L, Panzera P, Tandoi F, Carbotta G, Giannelli G, Santantonio T, et al. Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial. Transplantation. 2008;86(7):925–31.PubMedCrossRef Lupo L, Panzera P, Tandoi F, Carbotta G, Giannelli G, Santantonio T, et al. Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial. Transplantation. 2008;86(7):925–31.PubMedCrossRef
Metadaten
Titel
Oral steroid versus steroid pulse therapy for autoimmune pancreatitis: time to introduce new weapons
verfasst von
Ahad Eshraghian
Hamed Eshraghian
Publikationsdatum
01.01.2012
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 1/2012
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-011-0468-9

Weitere Artikel der Ausgabe 1/2012

Journal of Gastroenterology 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.